[ c G M P O l i g o n u c l e o t i d e s - Ta q D N A P o l y m e r a s e s ]
B R O A D
e x p e r t i s e
M A N u f A C T u R i N G
c a p a b i l i t i e sC l A s s i f i E D
c l e a n r o o m s
Custom Manufacturing solutionsfor Molecular Diagnostics Dx
R e a c h Dx c e l l e n c e
[ C u s t o m M a n u f a c t u r i n g s o l u t i o n s f o r M o l e c u l a r D i a g n o s t i c s ]
Table of conTenTs
experience True parTnership p.2
QualiTy ManageMenT sysTeM p.6
oligonucleoTide ManufacTuring p.10
ulTra pure diaMond Taq® p.14
conTacT us p.20
i v d @ e u r o g e n T e c . c o M w w w . e u r o g e n T e c . c o M
Experience true partnership
With over 25 years experience, eurogentec [part of
Kaneka corporation] is a leading supplier of high-
quality reagents for the life science community,
Diagnostic and pharmaceutical industries.
We offer a wide range of gMp oligonucleotide-
based components and gMp taq Dna polymerases
for Molecular Diagnostic [Dx] applications, such as
Molecular Diagnostic kits, lab Developed tests [asrs]
and companion Diagnostics.
eurogentec’s Quality Management system (QMs)
is compliant with the cgMp Quality system
regulation (Qsr). We are also iso 13485 certified for
oligonucleotide production and iso 13485 compliant
for production of Diamond taq® Dna polymerases.
our state-of-the-art cleanroom facilities meet class
100,000 (iso 8) and class 10,000 (iso 7) standards with
class 100 [iso 5] working zones.
Manufacturing sites located in europe, Belgium and
usa, san Diego offer redundancy and harmonization
of experience.
D i s c o v e r E u r o g e n t e c E x p e r t i s e … R e a c h Dx c e l l e n c e .
R e a c h Dx c e l l e n c e 2
Eurogentec's ability to provide complete custom solutions makes us unique
Testimonial
“
”
During the past months our
team has carefully evaluated
many different (suppliers)... A
few of the key success criteria
which your team impressed us
with (were): quality of
your products, your
responsiveness and receptivity
in addressing our many
questions and your impressive
GMP facilities and Quality
Management Systems.
Quote from a major North American diagnostic client
[Cu
sto
m M
an
ufa
ctu
rin
g s
olu
tio
ns
fo
r M
ole
cu
lar
Dia
gn
os
tic
s]
want to visit our facilities? check out our virtual Touron www.eurogentec.com/egt/virtual_tour/virtual-tour-ivd.html
Eurogentec's ability to provide complete custom solutions makes us unique
s Over 25 Years in Oligonucleotide
Synthesis
s Over 18 Years GMP Experience
s Complex Chemistry Expertise
s Proprietary Dyes & Quenchers
s From Small to Large Scale Oligonucleotide
Production
s GMP Taq DNA Polymerases
s Highly Qualified Production Teams
s Controlled Key Card Access
s Prevention of Cross Contamination
s Controlled Environment
s ISO 13485 Certified [Oligonucleotide
Production]
s ISO 13485 Compliant [GMP Taq DNA Polymerases Production]
s Compliance to FDA cGMP/QSR [21 CFR Part 820]
s EU IVD Directive 98/79 EC Compliance
for QMS
s Full Traceability
s Harmonized Production Sites
s Market Proximity
s Back-up Solutions
s Research, Pre-Diagnostic,
Diagnostic Grades
s ASRs
s Collaborative Project Development
s Fill and Finish
s Assay Set Assembly
R e a c h Dx c e l l e n c e
i v d @ e u r o g e n T e c . c o M w w w . e u r o g e n T e c . c o M
Regulatory
Compliance
Supply Chain
Reliability
Flexible
Custom
Solutions
Broad
Expertise
Manufacturing
Capabilities
Classified
Cleanrooms
4
[ C u s t o m M a n u f a c t u r i n g s o l u t i o n s f o r M o l e c u l a r D i a g n o s t i c s ]
eurogenTec is iso 13485 cerTified for producTion
and sales of ivd oligonucleoTides.
i v d @ e u r o g e n T e c . c o M w w w . e u r o g e n T e c . c o M
R e a c h Dx c e l l e n c e
Quality Management
Systemthe quality of each Diagnostic test component is
critical to perform accurate and trustworthy assays.
a QMs certified by an independent organization against
an international standard is an appropriate means
to assess the quality of a supplier’s manufacturing
process and the level of gMp compliance. good quality
must be built in during the manufacturing process
and gMp prevents errors.
as required by the iso 13485 standard, eurogentec
has implemented a comprehensive risk management
system based on the fMea (failure Mode and effects
analysis) to identify possible failure modes, determine
their potential effect(s) on product manufacturing and
identify actions to mitigate those failures.
in addition, all eurogentec's iVD oligonucleotides are
manufactured in classified cleanrooms.
6
[Cu
sto
m M
an
ufa
ctu
rin
g s
olu
tio
ns
fo
r M
ole
cu
lar
Dia
gn
os
tic
s]
Eurogentec is ISO I3485 certified by an FDA accredited organization
eurogentec is registered
with the fda under the
license registration number
3003830126 [eu]/3008004341
[us] as an analyte specific
reagent [asr] manufacturer. eurogentec is also registered
with the california departement
of public health fdb under
license number 52386.
iso 13485 certificate
is available on our website:
www.eurogentec.com/reach-dxcellence.html
i v d @ e u r o g e n T e c . c o M w w w . e u r o g e n T e c . c o M
chooSe gMp prevenT faiLureS avoid conTaMinaTion
8
Eurogentec is ISO I3485 certified by an FDA accredited organizationfor the Production and Sales of IVD Oligonucleotides
if you have
additionnal needs
that exceed our
standard regulatory
compliance systems,
custom-tailored plans
can be accomodated
to your requirements.
GMP Oligonucleotides✔ ISO 13485 Certified
✔ 21 CFR 820 Compliant✔ Knowledgeable & Experienced team
GMP Diamond Taq ®
✔ ✔ ISO 13485 Compliant✔ ✔ FDA cGMP/QSR [21 CFR Part 820] Compliant
✔ ✔ Stringent Document Change Control Procedures
Controlled Process & Full Traceability
✔ Rigorous Risk Analysis✔ Incoming QC of Raw Materials
✔ Checklists & SOPs✔ Extensive Batch Record with CoA
Released by QC-Authorized Persons✔ Qualification/Validation program
✔ Sample Retention
Constant Improvement✔ Audits from Internal,
Certification Body & Customers✔ CAPA Management
Exhaustive Environment Controls
✔ Class 100,000 and 10,000 Cleanrooms with Class 100 Hoods
✔ Strict Process Segregation
Strict Access Policy✔ Key Card Airlock Access
✔ Mandatory Gowning
R e a c h Dx c e l l e n c e
[ C u s t o m M a n u f a c t u r i n g s o l u t i o n s f o r M o l e c u l a r D i a g n o s t i c s ]
eurogenTec is developing efficienT
proprieTary dyes and Quenchers.
i v d @ e u r o g e n T e c . c o M w w w . e u r o g e n T e c . c o M
R e a c h Dx c e l l e n c e
Oligonucleotide Manufacturing
With over 25 years experience in oligonucleotide
manufacturing, eurogentec provides exceptional quality
products. the wide range of oligonucleotides proposed
is suitable from research to commercialization. all
oligonucleotides are manufactured by fully trained and
skilled chemists in an appropriate environment.
10
feaTureS BenefiTS
fda 21 cfr 820 compliant & iso 13485 certified c regulatory compliance
classified cleanroom manufacturing environment c contamination mitigation
continuous risk management process c Mitigate manufacturing errors
stringent product release Qc criteria c consistent lot-to-lot reproducibility
customized processes [synthesis scale, purification, fill & finish, Qc] c flexibility
appropriate grades following phases of development c cost-effective client solutions
comprehensive batch records c full process traceability
dedicated account contact person c continuous project oversight and real-time status updates
coMpLeTe cuSToM SoLuTionS
[Cu
sto
m M
an
ufa
ctu
rin
g s
olu
tio
ns
fo
r M
ole
cu
lar
Dia
gn
os
tic
s]
A flexible process that accomodates your requirements
in need
of gram scale
quantities of your
oligonucleotides?
eurogentec's large
scale oligonucleotide
production offers
a comprehensive
flexible service
adapted to your
needs.
1 2 3
Synthesis Purification Qc release Methods
> Synthesis scale from µg to multi-grams > Dedicated equipment and reagents> Development of custom modifications> Custom mixes of backbones
> Ion Exchange HPLC (IE-HPLC)> Reverse-Phase HPLC (RP-HPLC)> Dual HPLC> PAGE [Research grade only]> Ultrafiltration [Large scale only]> Dedicated purification columns
Typical QC Release Methods> Final mass (µmol, µg, OD)> Physical inspection> MALDI-TOF, ESI- and LC-Mass Spectrometry> Ion Exchange HPLC (IE-HPLC)> Reverse-Phase HPLC (RP-HPLC)> Capillary Gel Electrophoresis (CGE) Optional QC Release Methods > Direct sequencing using enzymatic cleavage and
MALDI-TOF MS> Enzymatic tests for DNA-enzyme conjugates> Probe/dye activity: fluorescence signal-to-noise
ratio, melting profile for Molecular Beacons> Bioburden
Customized QC Release Methods > QC release methods based on specific client
requirements
Product Stability Testing > Stability testing of oligonucleotides following
customized procedures
we offer
a selection of Qc
release methods,
any of which can be
incorporated into
the final Qc release
documentation.
visit our website for a complete list of modifications:http://www.eurogentec.com/gmp-oligos.html
i v d @ e u r o g e n T e c . c o M w w w . e u r o g e n T e c . c o M
12
5
A flexible process that accomodates your requirements
Your oLigo
Backbones Modifications qPCR ProbesDna, rna, lna®, 2’ o-Me rna, phosphorothioate and other chemistries
> 250 modifications availableDigoxigenin, thiol, Biotin, Dnp, fluorescent dyes, Quenchers, Wobbles...
Double-Dye probes,Molecular Beacons
Purificationsrp and ie-hplc (single or dual), page
Validated QC MethodsMs, hplc, cge…
Additional ServicesDedicated purification columns
tangential filtrationsterile filtration
optional Qc custom formulation
4
custom formulation options
Custom Formulation Options > Customized mixtures of individual oligonucleotides> Conjugated oligonucleotides (HRP, AP, synthetic peptides, proteins)> Lyophilized, dried or in solution (H2O, Tris Buffer or custom Buffer)> Bulk or aliquoted into tubes or plates> Customized fill & finish> Customized packaging and labeling
puriTy is More Than a nuMber!
puriTiy depends on various paraMeTers. esTablishing The appropriaTe level of oligonucleoTide puriTy for a given assay ensures balance beTween cosT and perforMance.
R e a c h Dx c e l l e n c e
[Cu
sto
m M
an
ufa
ctu
rin
g s
olu
tio
ns
fo
r M
ole
cu
lar
Dia
gn
os
tic
s]
The most exhaustive oligonucleotide range from Discovery through Commercialization
More info: http://www.eurogentec.com
Discovery
Oligo grades
ProcessFill & finishDedicated account contact person
Quality ManagementISO 9001 CertificationISO 13485 CertificationFDA 21 CFR Part 820 ComplianceQualification/Validation [Equipment & method]
ControlCleanroom class 100,000 [ISO 8]Cleanroom class 10,000 [ISO 7] on requestTraceabilityCertificate of Analysis [CoA]Batch record [archived for 5 years]Released by QC-authorized person
i v d @ e u r o g e n T e c . c o M w w w . e u r o g e n T e c . c o M
The most exhaustive oligonucleotide range from Discovery through Commercialization
dedicated Services
Documentation requirements differ
significantly as oligonucleotides progress
from Discovery and feasibility to Validation
and commercialization. eurogentec partners
choose from three progressively detailed levels
of documentation and overall quality assurance
appropriate for each phase of product development and
commercialization.
Discovery
Research
Feasability Commercialization
Pre-Diagnostic Diagnostic
Prototyping Validation
✔✔
✔
--✔
✔
-Partly documented
✔Minimal
✔
✔✔
✔✔✔✔
✔✔
Fully documented✔Full✔
OptionalOptional
✔
---
--
Basic - [TDS]
--
R e a c h Dx c e l l e n c e 14
[ C u s t o m M a n u f a c t u r i n g s o l u t i o n s f o r M o l e c u l a r D i a g n o s t i c s ]
gMp compliant c highly suited for diagnostic kits, lab services (with asrs) and demanding research
ultra-low residual dna content c <1 fg of genomic e. coli dna / Taq unit. Typically < 0.01 fg or 0.002 e. coli genome copies /Taq unit
purity c highly pure (> 98 %) and ultra-low bioburden (≤ 10 cfu/ml). Typically = 0 cfu/ml
sensitivity c amplification of dna templates even at very low concentrations
exceptional reproducibility c gMp process and stringent Qc ensuring lot-to-lot & results reproducibility
full traceability c Quality Management system fully compliant to iso 13 485 Medical device standards and fda’s Quality system regulations
customized fill & finish c cost-effective tailored solution
i v d @ e u r o g e n T e c . c o M w w w . e u r o g e n T e c . c o M
gMp ultra pure diamond Taq®
Polymerases
these ultra pure Dna polymerases show very good
sensitivity and exceptional reproducibility. as highly
thermostable enzymes, they offer an ideal solution for
Molecular Diagnostic and demanding research pcr
& qpcr. these enzymes have been validated by top
laboratories and several major diagnostic companies.
gMp compliant c highly suited for diagnostic kits, lab services (with asrs) and demanding research
ultra-low residual dna content c <1 fg of genomic e. coli dna / Taq unit. Typically < 0.01 fg or 0.002 e. coli genome copies /Taq unit
purity c highly pure (> 98 %) and ultra-low bioburden (≤ 10 cfu/ml). Typically = 0 cfu/ml
sensitivity c amplification of dna templates even at very low concentrations
exceptional reproducibility c gMp process and stringent Qc ensuring lot-to-lot & results reproducibility
full traceability c Quality Management system fully compliant to iso 13 485 Medical device standards and fda’s Quality system regulations
customized fill & finish c cost-effective tailored solution
generaL BenefiTS
R e a c h Dx c e l l e n c e 16
Select with confidence the Taq Polymerase that suits your application
www.eurogentec.com/gmp-taq.html
hot diamond Taq®
hgS diamond Taq®
diamond Taq® +++
+++ +++
+
+++ ++ +++ +++ +++ +++
+++ +++ ++
++ ++ +
+ TAQ-I032-100
TAQ-I010-100
TAQ-I020-100
+++
+
+++
++
PCR qPCR YieldSensitivity Low copy template
SpecificityDifficult template
(GC & AT rich)IP Burden Free Sample
> Shipping on dry ice. > Full traceability from production, storage to shipment of the product. > Tracking number sent to customer the day of the shipment.
Production Storage Order Shipment Shipping Tracking number
IVD Process Yes Yes Yes Yes Yes
Traceability
(shipment at -20 °C) (Sent to customer the day of the shipment)
documentation enzymes are provided with a Technical data sheet &
certificate of analysis. The Qc data are released by a Qc
authorized person and based on review of the complete
batch record.
storage conditions storage at -20 °c is recommended.
eurogentec out licenses
access to the hot diamond
Taq. if you plan to use the hdT
in diagnostic kits or services, you must obtain a license
from eurogentec. please contact eurogentec to
ask about the flexible cost-
effective licensing programs
that we offer.
[Cu
sto
m M
an
ufa
ctu
rin
g s
olu
tio
ns
fo
r M
ole
cu
lar
Dia
gn
os
tic
s]
i v d @ e u r o g e n T e c . c o M w w w . e u r o g e n T e c . c o M
Select with confidence the Taq Polymerase that suits your application
> Represents a completely new “HotStart concept”. Neither accomplished through chemical, modification nor a blocking antibody but a proprietary agent.
> Prevents non-specific polymerization. [Preventing primer-dimer formation, increasing
the PCR yield of specific products]
> Needs a short activation time. [100 % activated during the first PCR cycle]
> Compatible with all existing protocols. [from 20 seconds to 15 minutes at 95 °C]
> Customized fill & finish.
> The DiamondTaq® has a very good fidelity and exhibits high performance in
many demanding applications.
For difficult and GC rich
template amplification
High Performance Heat stable > Chemically modified HotStart Taq DNA Polymerases. [Fully inactivated vs Ab modified HotStart]
> Requires a thermal activation of 10 minutes at 95 °C to reach maximal initial activity.[No activity below 74 °C before activation]
> More heat-stable than commonly used Taq DNA Polymerases. [DNA fragments as long as 2 kb can be efficiently amplified]
> Provides efficient amplification of specific products.
> Customized fill & finish.
HotStart Taq HotStart TaqTaq
a Major product
Diamond taq® polymerases are purified from
recombinant escherichia coli bacteria containing the
thermus aquaticus Dna polymerase gene. this
thermophilic eubacterium strain lacks taqi restriction
endonuclease and catalyzes 5’p 3’ synthesis of Dna
with no detectable 3’p 5’ exonuclease activity. the enzyme has 3’ extendase
activity allowing ta cloning.
Diamond Taq® HGS Diamond
Taq®Hot Diamond
Taq®
RPrevents non-specific polymerizationRRecommended for long & difficult templates
RPrevents non-specific
polymerizationRRecommended
for multiplex assays
+ Eurogentec's proprietary modification
+ Chemical modification
R e a c h Dx c e l l e n c e 18
[Cu
sto
m M
an
ufa
ctu
rin
g s
olu
tio
ns
fo
r M
ole
cu
lar
Dia
gn
os
tic
s]
Great experimental results that keep you smiling
free samples can be requested at [email protected]
appearance*c
colorless solution
identity (sds-page) c Mw approx. 95 kda
volume activity c ≥ 5 u/µl
purity (sds-page) c > 98 %
performance test: pcr - l dna* c 0.5 kb fragment positive down to 5 pg
performance test: pcr - 18 s dna* c 0.1 kb fragment positive down to 10 pg
ribonucleases (up to 10 u, 1 h, 37 °c) c not detectable
endonucleases, exonucleases, nicking activity (up to 30 u, 16 h, 65 °c) c not detectable
e.coli residual dna c < 1 fg / Taq unit
bioburden* c ≤ 10 cfu/ml
stability* c 24 months (at -20 °c) from date of manufacture
animal-derived additives* c none
hotstart [hgs diamond Taq®] c no detectable amplification without 95 °c activation
performance test pcr-numb dna [hot diamond Taq®] c 0.3 kb fragment positive down to 10 pg
diaMond TaQ® faMiLY
paraMeTerS SpecificaTionS
* Also for buffer & MgCl2
HGS Diamond Taq® was evaluated for its ability to amplify a PCR template of 0.5 kb (lDNA) for several activation times. PCR products were analyzed by gel electrophoresis.
HGs Diamond taq®
20 sec. 5 min. 10 min.
High quality results obtained using the HGS Diamond Taq® (twice serial dilutions) on ß-actin cDNA performed in singleplex Taqman assay.
0.3
0.2
fluo
resc
ence
(∆R
n)
0.1
0.0
2 4 6 8 10 12 14 16 18 20
CYCLE
22 24 26 36 38 4028 30 32 34
l HGS Diamond Taq® needs at least 5 min. activation time to amplifly DNA fragment
hgS diamond Taq®diamond Taq®
EurogentecIVD-GMP Taq
Competitor GMP Taq
Smart Ladder
1000 100 50 5 1000 100 50 5DNA (pg):
500 bp
Eurogentec (Goldstar ®)RUO Taq
1000 100 50 5
Smart Ladder
Diamond Taq®
Competitor GMP Taq
Diamond Taq® was evaluated against competitor GMP Taq for its ability to amplify different amounts (from 5 to 1000 pg) of a 0.5 kb PCR template (lDNA). PCR products were analyzed by gel electrophoresis.
Diamond taq® compared to competitor gMp taq
l Diamond Taq® performance is similar or higher than competitor GMP Taq
i v d @ e u r o g e n T e c . c o M w w w . e u r o g e n T e c . c o M
Great experimental results that keep you smiling
R e a c h Dx c e l l e n c e
CYCLE
Hot Diamond Taq® was evaluated using from 20 secondes to 10 minutes as activation time for its ability to amplify 1 and 5 pg of lDNA. PCR products were analyzed by gel electrophoresis.
l Hot Diamond Taq® needs very short activation time [20 sec. are sufficient]
Hot Diamond Taq® (HDT) & Diamond Taq® (DT) were evaluated against HotStart competitors (C1, 2 & 4 – Chemical modification; C3 - Antibody) for their ability to amplify difficult and GC rich templates. PCR products were analyzed by gel electrophoresis.
Hot Diamond taq® compared to hotstart competitors
HDT C1 C2 C3 C4 DTDT
Performance test on difficult template: gDNA NUMB (306b)
DTC4C3C1 C2HDT
Performance test on GC rich template: SCO3449 (152b) – 72 % GC
l Hot Diamond Taq® is highly suitable for difficult and GC rich template amplifications
activation time
hot diamond Taq®
0.3
0.2
fluo
resc
ence
(dR
n)
0.1
0.0
2 4 6 8 10 12 14 16 18 20 22 24 26 36 38 4028 30 32 34
diamond Taq® family [5 u/µl]
R Mgcl2 solution: 25 mM Mgcl
2.
R enzyme storage buffer: 20 mM Tris-hcl, 1 mM dTT, 0.1 mM edTa, 0.1 M Kcl, 0.5 % (v/v)
nonidet p40, 0.5 % (v/v) Tween 20, 50 % (v/v)
glycerol and stabilizer, ph 8.0 (19 °c).
R 10x reaction buffer:
750 mM Tris-hcl, 200 mM (nh4)2so
4, 0.1 %
(v/v) Tween 20 and stabilizer, ph 8.8 (at 19 °c).
except hgs diamond Taq®
150 mM Tris-hcl, 500 mM Kci and stabilizer, ph 8.5 (at 19 °c).
High quality results obtained using the Hot Diamond Taq® (twice serial dilutions) on ß-actin cDNA performed in singleplex Taqman assay.
20
R e a c h Dx c e l l e n c e
Confidentiality Agreements
We treat all details including oligonucleotide sequences, probe formats,
manufacturing specifications, product formulations and business plans
with utmost confidentiality.
client consultation
We encourage regular face-to-face meetings or online teleconferences
to ensure clear understanding of manufacturing requirements and
specifications. in addition, our technical experts are available for
consultation on all aspects of manufacturing and regulatory compliance.
[Cu
sto
m M
an
ufa
ctu
rin
g s
olu
tio
ns
fo
r M
ole
cu
lar
Dia
gn
os
tic
s]
Partnering with Eurogentec… a Dedicated Process
contact
For EU: [email protected] US : [email protected]
We consider each customer with utmost respect. Our specialists are available to you throughout the entire evolution of your project.
i v d @ e u r o g e n T e c . c o M w w w . e u r o g e n T e c . c o M
Supplier Questionnaires and audits
We encourage site visits and formal audits of our
facilities. please discuss submission of supplier/
Vendor questionnaires or arrangements for on-
site facility audits with your iVD representative.
Quotations
Quotations are typically short-term guarantees
of pricing based on product descriptions,
manufacturing specifications, shipping and
delivery information.
pilot Studies for evaluation and
validation
evaluation and validation projects are key
components of the vendor evaluation process
and we work closely with you to provide these
services.
Partnering with Eurogentec… a Dedicated Process
Supply or purchase agreements
supply or purchase agreements typically guarantee
pricing for one or more years, can include discounted
pricing based on annualized usage forecasts, can
incorporate our partners’ detailed and comprehensive
customized manufacturing specifications and may
contain additional client terms and conditions.
dedicated account contact person
a dedicated account contact person acts as your
advocate in the production plant, monitors all aspects
of the production process and will provide you with
frequent real-time updates during each production
run. clients are also provided a confidential email
address that goes directly to the account contact
person to ensure a rapid response to all inquiries.
R e a c h Dx c e l l e n c e 22
D i s c o v e r E u r o g e n t e c E x p e r t i s e &
*
Europe
Tel.: +32 4 372 74 00
Fax: +32 4 372 75 00
5, Rue Bois Saint-Jean - 4102 Seraing - Belgium - EU
North America
Tel.: +1-510-896-1350
Fax: +1 510-791-9573
34801 Campus Drive - Fremont, CA 94555 - USA
R e a c h Dx c e l l e n c e E
uro
ge
nte
c i
s p
art
of
Ka
ne
ka
Co
rpo
rati
on
© e
ur
og
ente
c 2
012
• p
ho
tos
eur
og
ente
c &
oll
y- f
oto
lia
iVD
-Br
o-1
113-
V2-e
u
* for production & sales of iVD oligonucleotides
Trademark Labels and License statementsDiamond Taq® products and Hot Diamond Taq® products are
registered trademarks of Eurogentec S.A. and are covered by
international pending patent application (PCT/EP2008/067435). Hot
Diamond Taq® products are sold exclusively for research use only
by the purchaser and may not be used for clinical or diagnostic
purposes, resold, distributed or re-packaged without the prior
written consent of Eurogentec S.A. It may be necessary to obtain
a separate license for certain patented applications in which the
Hot Diamond Taq® products are used. • Roche Enzyme Products
Conveying Polymerase Patent Rights Purchase of this product
includes an immunity from suit under patents specified in the product
insert to use only the amount purchased for the purchaser’s own
internal research. No other patent rights are conveyed expressly,
by implication, or by estoppel. Further information on purchasing
licenses may be obtained by contacting the Dierctor of Licensing,
Applied Biosystems, 850 Lincoln Centre Drive, Foster City, California
94404, USA. • Chemically-Modified Hot-Start Polymerase
Reagents and Kits Purchase of this product includes an immunity
from suit under patents specified in the product insert to use only
the amount purchased for the purchaser’s own internal research.
No other patent rights are conveyed expressly, by implication,
or by estoppel. Further information on purchasing licenses may
be obtained by contacting the Dierctor of Licensing, Applied
Biosystems, 850 Lincoln Centre Drive, Foster City, California 94404,
USA. • Licensed dsDNA-Binding Dye Research Kits Purchase
of this product includes an immunity from suit under patents
specified in the product insert to use only the amount purchased
for the purchaser’s own internal research. No other patent rights
are conveyed expressly, by implication, or by estoppel. Further
information on purchasing licenses may be obtained by contacting
the Dierctor of Licensing, Applied Biosystems, 850 Lincoln Centre
Drive, Foster City, California 94404, USA. • Custom Molecular
Beacon Probes The use of Custom Molecular Beacon Probes
employs the following patent rights licensed to Eurogentec S.A. from
The Public Health Research Institute of the City of New York: (a) the
claims of U.S. Patent Application Serial No. 08/439,819; (b) the claims
of U.S. Patent Application Serial No. 08/990,176; and (c) all patent
application claims and all patent claims, U.S. and foreign, that cover
improvements in the foregoing claimed probes, kits and assays and
whose subjects are inventions and discoveries that are made by the
Public Health Research Institute of New York. The use of Custom
Molecular Beacon Probes is limited to the field of use comprising the
internal use by an end user of a product solely in assays of the end
user (or in applications of the end user’s customer, if the end user is
performing contract research) in scientific research and development.
• LNA® oligonucleotides are registered trademark of Exiqon A/S
and produced under license from Exiqon A/S for research use only. Not
for resale or for therapeutic use or use in humans. • Probes Use of
this product is covered by one or more of the following US patents
and corresponding patent claims outside the US: 5,538,848, 5,723,591,
5,876,930, 6,030,787, 6,258,569 and 5,804,375 (claims 1-12 only). The
purchase of this product includes a limited, non-transferable immunity
from suit under the foregoing patent claims for using only this amount
of product for the purchaser’s own internal research. Except under
separate license rights available from Applied Biosysterns, no right
under any other patent claim, or to perform commercial services of any
kind, including without limitation reporting the results of purchaser’s
activities for a fee or other commercial consideration, or to sublicense,
repackage with other products, or resell in any form, is conveyed
expressly, by implication, or by estoppel. This product is for research
use only. Diagnostic uses under Roche patents require a separate
license from Roche. Further information on purchasing licenses may
be obtained from the Director of Licensing, Applied Biosystems, 850
Lincoln Centre Drive, Foster City, California 94404, USA.